{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:09:14Z","timestamp":1791929354225,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["20K07073"],"award-info":[{"award-number":["20K07073"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["20K09293"],"award-info":[{"award-number":["20K09293"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["KL2-TR-002385"],"award-info":[{"award-number":["KL2-TR-002385"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nara Prefecture Health Promotion Center","award":["R02-2"],"award-info":[{"award-number":["R02-2"]}]},{"name":"Nara Medical University Grant-in-Aid for Collaborative Research Projects"},{"name":"a research grant from Kobayashi Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-68433-4","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T12:54:32Z","timestamp":1722257672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Increased levels of circulating cell-free DNA in COVID-19 patients with respiratory failure"],"prefix":"10.1038","volume":"14","author":[{"given":"Akihiko","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuki","family":"Wakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Homma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Kyotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisakazu","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuei-Pin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Yoshizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiichi","family":"Nakahira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"68433_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"B Hu","year":"2021","unstructured":"Hu, B., Guo, H., Zhou, P. & Shi, Z. L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 19, 141\u2013154. https:\/\/doi.org\/10.1038\/s41579-020-00459-7 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"68433_CR2","doi-asserted-by":"publisher","first-page":"13809","DOI":"10.1038\/s41598-020-70526-9","volume":"10","author":"L Kananen","year":"2020","unstructured":"Kananen, L. et al. Circulating cell-free DNA level predicts all-cause mortality independent of other predictors in the Health 2000 survey. Sci. Rep. 10, 13809. https:\/\/doi.org\/10.1038\/s41598-020-70526-9 (2020).","journal-title":"Sci. Rep."},{"key":"68433_CR3","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.chest.2019.07.014","volume":"156","author":"JS Harrington","year":"2019","unstructured":"Harrington, J. S. et al. Circulating mitochondrial DNA as predictor of mortality in critically ill patients: A systematic review of clinical studies. Chest 156, 1120\u20131136. https:\/\/doi.org\/10.1016\/j.chest.2019.07.014 (2019).","journal-title":"Chest"},{"key":"68433_CR4","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1089\/ars.2015.6407","volume":"23","author":"K Nakahira","year":"2015","unstructured":"Nakahira, K., Hisata, S. & Choi, A. M. The roles of mitochondrial damage-associated molecular patterns in diseases. Antioxid. Redox Signal. 23, 1329\u20131350. https:\/\/doi.org\/10.1089\/ars.2015.6407 (2015).","journal-title":"Antioxid. Redox Signal."},{"key":"68433_CR5","doi-asserted-by":"publisher","first-page":"13648","DOI":"10.1038\/s41598-019-50044-z","volume":"9","author":"JA Stortz","year":"2019","unstructured":"Stortz, J. A. et al. Cell-free nuclear, but not mitochondrial, DNA concentrations correlate with the early host inflammatory response after severe trauma. Sci. Rep. 9, 13648. https:\/\/doi.org\/10.1038\/s41598-019-50044-z (2019).","journal-title":"Sci. Rep."},{"key":"68433_CR6","doi-asserted-by":"publisher","first-page":"1196035","DOI":"10.3389\/fpsyt.2023.1196035","volume":"14","author":"G Al-Kafaji","year":"2023","unstructured":"Al-Kafaji, G., Jahrami, H. A., Alwehaidah, M. S., Alshammari, Y. & Husni, M. Mitochondrial DNA copy number in autism spectrum disorder and attention deficit hyperactivity disorder: A systematic review and meta-analysis. Front. Psychiatry 14, 1196035. https:\/\/doi.org\/10.3389\/fpsyt.2023.1196035 (2023).","journal-title":"Front. Psychiatry"},{"key":"68433_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.33549\/physiolres.934242","volume":"69","author":"PV Camuzi Zovico","year":"2020","unstructured":"Camuzi Zovico, P. V. et al. Cell-free DNA as an obesity biomarker. Physiol. Res. 69, 515\u2013520. https:\/\/doi.org\/10.33549\/physiolres.934242 (2020).","journal-title":"Physiol. Res."},{"key":"68433_CR8","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.mito.2011.06.005","volume":"11","author":"A Cossarizza","year":"2011","unstructured":"Cossarizza, A. et al. Increased plasma levels of extracellular mitochondrial DNA during HIV infection: A new role for mitochondrial damage-associated molecular patterns during inflammation. Mitochondrion 11, 750\u2013755. https:\/\/doi.org\/10.1016\/j.mito.2011.06.005 (2011).","journal-title":"Mitochondrion"},{"key":"68433_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/QAI.0000000000002993","volume":"90","author":"CD Johnston","year":"2022","unstructured":"Johnston, C. D. et al. Plasma cell-free mitochondrial DNA as a marker of geriatric syndromes in older adults with HIV. J. Acquir. Immune Defic. Syndr. 90, 456\u2013462. https:\/\/doi.org\/10.1097\/QAI.0000000000002993 (2022).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"68433_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s13365-023-01122-6","volume":"29","author":"CD Johnston","year":"2023","unstructured":"Johnston, C. D. et al. Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV. J. Neurovirol. 29, 218\u2013224. https:\/\/doi.org\/10.1007\/s13365-023-01122-6 (2023).","journal-title":"J. Neurovirol."},{"key":"68433_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.112215","volume":"207","author":"O Bulgakova","year":"2022","unstructured":"Bulgakova, O. et al. The level of free-circulating mtDNA in patients with radon-induced lung cancer. Environ. Res. 207, 112215. https:\/\/doi.org\/10.1016\/j.envres.2021.112215 (2022).","journal-title":"Environ. Res."},{"key":"68433_CR12","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1164\/rccm.201612-2480OC","volume":"196","author":"C Ryu","year":"2017","unstructured":"Ryu, C. et al. Extracellular mitochondrial DNA is generated by fibroblasts and predicts death in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 196, 1571\u20131581. https:\/\/doi.org\/10.1164\/rccm.201612-2480OC (2017).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"68433_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001577","volume":"10","author":"K Nakahira","year":"2013","unstructured":"Nakahira, K. et al. Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: Derivation and validation. PLoS Med. 10, e1001577. https:\/\/doi.org\/10.1371\/journal.pmed.1001577 (2013) (discussion e1001577).","journal-title":"PLoS Med."},{"key":"68433_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12931-023-02658-1","volume":"25","author":"SA Ware","year":"2024","unstructured":"Ware, S. A. et al. Cell-free DNA levels associate with COPD exacerbations and mortality. Respir. Res. 25, 42. https:\/\/doi.org\/10.1186\/s12931-023-02658-1 (2024).","journal-title":"Respir. Res."},{"key":"68433_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12931-021-01707-x","volume":"22","author":"WZ Zhang","year":"2021","unstructured":"Zhang, W. Z. et al. Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort. Respir Res 22, 126. https:\/\/doi.org\/10.1186\/s12931-021-01707-x (2021).","journal-title":"Respir Res"},{"key":"68433_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.blre.2015.12.004","volume":"30","author":"PC Liaw","year":"2016","unstructured":"Liaw, P. C., Ito, T., Iba, T., Thachil, J. & Zeerleder, S. DAMP and DIC: The role of extracellular DNA and DNA-binding proteins in the pathogenesis of DIC. Blood Rev. 30, 257\u2013261. https:\/\/doi.org\/10.1016\/j.blre.2015.12.004 (2016).","journal-title":"Blood Rev."},{"key":"68433_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","volume":"20","author":"T Gong","year":"2020","unstructured":"Gong, T., Liu, L., Jiang, W. & Zhou, R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat. Rev. Immunol. 20, 95\u2013112. https:\/\/doi.org\/10.1038\/s41577-019-0215-7 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"68433_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00760-x","author":"S Marchi","year":"2022","unstructured":"Marchi, S., Guilbaud, E., Tait, S. W. G., Yamazaki, T. & Galluzzi, L. Mitochondrial control of inflammation. Nat. Rev. Immunol. https:\/\/doi.org\/10.1038\/s41577-022-00760-x (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"68433_CR19","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.143299","author":"D Scozzi","year":"2021","unstructured":"Scozzi, D. et al. Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.143299 (2021).","journal-title":"JCI Insight"},{"key":"68433_CR20","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147610","author":"TE Andargie","year":"2021","unstructured":"Andargie, T. E. et al. Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.147610 (2021).","journal-title":"JCI Insight"},{"key":"68433_CR21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/1753425921995577","volume":"27","author":"R Hammad","year":"2021","unstructured":"Hammad, R. et al. Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity. Innate Immun. 27, 240\u2013250. https:\/\/doi.org\/10.1177\/1753425921995577 (2021).","journal-title":"Innate Immun."},{"key":"68433_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.754708","volume":"11","author":"JJ Valdes-Aguayo","year":"2021","unstructured":"Valdes-Aguayo, J. J. et al. Peripheral blood mitochondrial dna levels were modulated by SARS-CoV-2 infection severity and its lessening was associated with mortality among hospitalized patients with COVID-19. Front. Cell Infect. Microbiol. 11, 754708. https:\/\/doi.org\/10.3389\/fcimb.2021.754708 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"68433_CR23","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.amjms.2022.06.027","volume":"364","author":"Y Miyata","year":"2022","unstructured":"Miyata, Y. et al. Serum cystatin C and CRP are early predictive biomarkers for emergence of hypoxia in COVID-19. Am. J. Med. Sci. 364, 706\u2013713. https:\/\/doi.org\/10.1016\/j.amjms.2022.06.027 (2022).","journal-title":"Am. J. Med. Sci."},{"key":"68433_CR24","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1038\/s41598-022-09544-8","volume":"12","author":"Y Fukuda","year":"2022","unstructured":"Fukuda, Y. et al. Serum IL-28A\/IFN-lambda2 is linked to disease severity of COVID-19. Sci. Rep. 12, 5458. https:\/\/doi.org\/10.1038\/s41598-022-09544-8 (2022).","journal-title":"Sci. Rep."},{"key":"68433_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245927","volume":"16","author":"Y Fukuda","year":"2021","unstructured":"Fukuda, Y. et al. Utility of SpO2\/FiO2 ratio for acute hypoxemic respiratory failure with bilateral opacities in the ICU. PLoS ONE 16, e0245927. https:\/\/doi.org\/10.1371\/journal.pone.0245927 (2021).","journal-title":"PLoS ONE"},{"key":"68433_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268431","volume":"17","author":"JH Kim","year":"2022","unstructured":"Kim, J. H. et al. ROX index and SpO2\/FiO2 ratio for predicting high-flow nasal cannula failure in hypoxemic COVID-19 patients: A multicenter retrospective study. PLoS ONE 17, e0268431. https:\/\/doi.org\/10.1371\/journal.pone.0268431 (2022).","journal-title":"PLoS ONE"},{"key":"68433_CR27","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1001\/jama.2020.16349","volume":"324","author":"CD Spinner","year":"2020","unstructured":"Spinner, C. D. et al. Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: A randomized clinical trial. JAMA 324, 1048\u20131057. https:\/\/doi.org\/10.1001\/jama.2020.16349 (2020).","journal-title":"JAMA"},{"key":"68433_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n436","volume":"372","author":"AH Attaway","year":"2021","unstructured":"Attaway, A. H., Scheraga, R. G., Bhimraj, A., Biehl, M. & Hatipoglu, U. Severe covid-19 pneumonia: Pathogenesis and clinical management. BMJ 372, n436. https:\/\/doi.org\/10.1136\/bmj.n436 (2021).","journal-title":"BMJ"},{"key":"68433_CR29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2203437119","volume":"119","author":"C Iwamura","year":"2022","unstructured":"Iwamura, C. et al. Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity. Proc. Natl. Acad. Sci. USA 119, e2203437119. https:\/\/doi.org\/10.1073\/pnas.2203437119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68433_CR30","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ajem.2020.11.025","volume":"45","author":"L Szarpak","year":"2021","unstructured":"Szarpak, L. et al. Lactate dehydrogenase level as a COVID-19 severity marker. Am. J. Emerg. Med. 45, 638\u2013639. https:\/\/doi.org\/10.1016\/j.ajem.2020.11.025 (2021).","journal-title":"Am. J. Emerg. Med."},{"key":"68433_CR31","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/postgradmedj-2020-139542","volume":"98","author":"JW Martha","year":"2022","unstructured":"Martha, J. W., Wibowo, A. & Pranata, R. Prognostic value of elevated lactate dehydrogenase in patients with COVID-19: A systematic review and meta-analysis. Postgrad. Med. J. 98, 422\u2013427. https:\/\/doi.org\/10.1136\/postgradmedj-2020-139542 (2022).","journal-title":"Postgrad. Med. J."},{"key":"68433_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40560-020-00466-z","volume":"8","author":"Y Yao","year":"2020","unstructured":"Yao, Y. et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: A case control study. J. Intensive Care 8, 49. https:\/\/doi.org\/10.1186\/s40560-020-00466-z (2020).","journal-title":"J. Intensive Care"},{"key":"68433_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.thromres.2020.07.047","volume":"195","author":"HH Yu","year":"2020","unstructured":"Yu, H. H., Qin, C., Chen, M., Wang, W. & Tian, D. S. D-dimer level is associated with the severity of COVID-19. Thromb. Res. 195, 219\u2013225. https:\/\/doi.org\/10.1016\/j.thromres.2020.07.047 (2020).","journal-title":"Thromb. Res."},{"key":"68433_CR34","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1002\/iid3.517","volume":"9","author":"M Alroomi","year":"2021","unstructured":"Alroomi, M. et al. Ferritin level: A predictor of severity and mortality in hospitalized COVID-19 patients. Immun. Inflamm. Dis. 9, 1648\u20131655. https:\/\/doi.org\/10.1002\/iid3.517 (2021).","journal-title":"Immun. Inflamm. Dis."},{"key":"68433_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/v14020321","author":"R Stawski","year":"2022","unstructured":"Stawski, R., Nowak, D. & Perdas, E. Cell-free DNA: Potential application in COVID-19 diagnostics and management. Viruses https:\/\/doi.org\/10.3390\/v14020321 (2022).","journal-title":"Viruses"},{"key":"68433_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bdq.2019.100087","volume":"17","author":"AJ Bronkhorst","year":"2019","unstructured":"Bronkhorst, A. J., Ungerer, V. & Holdenrieder, S. The emerging role of cell-free DNA as a molecular marker for cancer management. Biomol. Detect. Quantif. 17, 100087. https:\/\/doi.org\/10.1016\/j.bdq.2019.100087 (2019).","journal-title":"Biomol. Detect. Quantif."},{"key":"68433_CR37","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201129","author":"FP Veras","year":"2020","unstructured":"Veras, F. P. et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20201129 (2020).","journal-title":"J. Exp. Med."},{"key":"68433_CR38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138999","author":"Y Zuo","year":"2020","unstructured":"Zuo, Y. et al. Neutrophil extracellular traps in COVID-19. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.138999 (2020).","journal-title":"JCI Insight"},{"key":"68433_CR39","doi-asserted-by":"publisher","first-page":"107602962110109","DOI":"10.1177\/10760296211010976","volume":"27","author":"H Zhan","year":"2021","unstructured":"Zhan, H. et al. Diagnostic value of d-dimer in COVID-19: A meta-analysis and meta-regression. Clin. Appl. Thromb. Hemost. 27, 10760296211010976. https:\/\/doi.org\/10.1177\/10760296211010976 (2021).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"68433_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fcvm.2019.00153","volume":"6","author":"H Melchinger","year":"2019","unstructured":"Melchinger, H., Jain, K., Tyagi, T. & Hwa, J. Role of platelet mitochondria: Life in a nucleus-free zone. Front. Cardiovasc. Med. 6, 153. https:\/\/doi.org\/10.3389\/fcvm.2019.00153 (2019).","journal-title":"Front. Cardiovasc. Med."},{"key":"68433_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-0035-1564835","volume":"42","author":"T Gremmel","year":"2016","unstructured":"Gremmel, T., Frelinger, A. L. 3rd. & Michelson, A. D. Platelet physiology. Semin. Thromb. Hemost. 42, 191\u2013204. https:\/\/doi.org\/10.1055\/s-0035-1564835 (2016).","journal-title":"Semin. Thromb. Hemost."},{"key":"68433_CR42","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1182\/blood-2014-05-573543","volume":"124","author":"LH Boudreau","year":"2014","unstructured":"Boudreau, L. H. et al. Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood 124, 2173\u20132183. https:\/\/doi.org\/10.1182\/blood-2014-05-573543 (2014).","journal-title":"Blood"},{"key":"68433_CR43","unstructured":"Farhana, A. & Lappin, S. L. StatPearls (2022)."},{"key":"68433_CR44","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.40364","volume":"4","author":"AL Beatty","year":"2021","unstructured":"Beatty, A. L. et al. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA . Open 4, e2140364. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.40364 (2021).","journal-title":"JAMA . Open"},{"key":"68433_CR45","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","volume":"21","author":"C Menni","year":"2021","unstructured":"Menni, C. et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: A prospective observational study. Lancet Infect. Dis. 21, 939\u2013949. https:\/\/doi.org\/10.1016\/S1473-3099(21)00224-3 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"68433_CR46","doi-asserted-by":"publisher","unstructured":"Update to living systematic review on drug treatments for covid-19. BMJ 378, o1717, https:\/\/doi.org\/10.1136\/bmj.o1717 (2022).","DOI":"10.1136\/bmj.o1717"},{"key":"68433_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00642-4","author":"N Murakami","year":"2022","unstructured":"Murakami, N. et al. Therapeutic advances in COVID-19. Nat. Rev. Nephrol. https:\/\/doi.org\/10.1038\/s41581-022-00642-4 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"68433_CR48","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","volume":"386","author":"J Hammond","year":"2022","unstructured":"Hammond, J. et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N. Engl. J. Med. 386, 1397\u20131408. https:\/\/doi.org\/10.1056\/NEJMoa2118542 (2022).","journal-title":"N. Engl. J. Med."},{"key":"68433_CR49","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel, J. H. et al. Remdesivir for the treatment of Covid-19\u2014final report. N. Engl. J. Med. 383, 1813\u20131826. https:\/\/doi.org\/10.1056\/NEJMoa2007764 (2020).","journal-title":"N. Engl. J. Med."},{"key":"68433_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12979-020-00212-x","volume":"18","author":"S Mohammad","year":"2021","unstructured":"Mohammad, S. et al. Obesity and COVID-19: What makes obese host so vulnerable?. Immun. Ageing 18, 1. https:\/\/doi.org\/10.1186\/s12979-020-00212-x (2021).","journal-title":"Immun. Ageing"},{"key":"68433_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100789","volume":"33","author":"FV Gerayeli","year":"2021","unstructured":"Gerayeli, F. V. et al. COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis. EClinicalMedicine 33, 100789. https:\/\/doi.org\/10.1016\/j.eclinm.2021.100789 (2021).","journal-title":"EClinicalMedicine"},{"key":"68433_CR52","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/ije\/dyab216","volume":"51","author":"D Onozuka","year":"2022","unstructured":"Onozuka, D. et al. Reduced mortality during the COVID-19 outbreak in Japan, 2020: A two-stage interrupted time-series design. Int. J. Epidemiol. 51, 75\u201384. https:\/\/doi.org\/10.1093\/ije\/dyab216 (2022).","journal-title":"Int. J. Epidemiol."},{"key":"68433_CR53","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1186\/s12879-021-06536-3","volume":"21","author":"ZG Dessie","year":"2021","unstructured":"Dessie, Z. G. & Zewotir, T. Mortality-related risk factors of COVID-19: A systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect. Dis. 21, 855. https:\/\/doi.org\/10.1186\/s12879-021-06536-3 (2021).","journal-title":"BMC Infect. Dis."},{"key":"68433_CR54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijid.2020.07.029","volume":"99","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis. Int. J. Infect. Dis. 99, 47\u201356. https:\/\/doi.org\/10.1016\/j.ijid.2020.07.029 (2020).","journal-title":"Int. J. Infect. Dis."},{"key":"68433_CR55","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J. & Prescott, H. C. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA 324, 782\u2013793. https:\/\/doi.org\/10.1001\/jama.2020.12839 (2020).","journal-title":"JAMA"},{"key":"68433_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3379","volume":"370","author":"A Agarwal","year":"2020","unstructured":"Agarwal, A. et al. A living WHO guideline on drugs for covid-19. BMJ 370, m3379. https:\/\/doi.org\/10.1136\/bmj.m3379 (2020).","journal-title":"BMJ"},{"key":"68433_CR57","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.133984","author":"WZ Zhang","year":"2020","unstructured":"Zhang, W. Z. et al. Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.133984 (2020).","journal-title":"JCI Insight"},{"key":"68433_CR58","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1258\/acb.2010.009173","volume":"47","author":"VG Moreira","year":"2010","unstructured":"Moreira, V. G., Prieto, B., Rodriguez, J. S. & Alvarez, F. V. Usefulness of cell-free plasma DNA, procalcitonin and C-reactive protein as markers of infection in febrile patients. Ann. Clin. Biochem. 47, 253\u2013258. https:\/\/doi.org\/10.1258\/acb.2010.009173 (2010).","journal-title":"Ann. Clin. Biochem."},{"key":"68433_CR59","doi-asserted-by":"publisher","first-page":"7728","DOI":"10.3892\/mmr.2015.4334","volume":"12","author":"Q Yang","year":"2015","unstructured":"Yang, Q. et al. Evaluation of suitable control genes for quantitative polymerase chain reaction analysis of maternal plasma cell-free DNA. Mol. Med. Rep. 12, 7728\u20137734. https:\/\/doi.org\/10.3892\/mmr.2015.4334 (2015).","journal-title":"Mol. Med. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68433-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68433-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68433-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T13:01:23Z","timestamp":1722258083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68433-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["68433"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-68433-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"18 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17399"}}